3 Things to Expect From Teladoc in 2021

Teladoc (NYSE: TDOC) has played a vital role in allowing people to safely get the healthcare they need during the pandemic, and has expanded impressively in the process. In addition to its incredible organic growth in 2020, management also made two major acquisitions. But what can investors expect from the telehealth leader this year?

Image source: Getty Images

The first thing to expect is that Teladoc may experience some difficulties in integrating the larger of those two acquisitions. Livongo, which it purchased for $18.5 billion, offers chronic condition management through technology, virtual care, and coaching. It also boasts world-class customer loyalty and employees who are deeply committed to its mission. In fact, one-third of Livongo employees actually use its services. But several C-suite executives are leaving now that the deal has closed, and blending the two cultures may prove more difficult than shareholders are expecting.

Continue reading

Source Fool.com